Mainz, Germany

Kirsten Vormbrock

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Hamburg, DE (2019)
  • Mainz, DE (2018 - 2023)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Kirsten Vormbrock

Introduction

Kirsten Vormbrock is an innovative inventor based in Mainz, Germany, renowned for her contributions to cancer therapy through the development of targeted treatments. With a total of five patents to her name, she has made significant strides in the field of oncology, particularly focusing on breast cancer.

Latest Patents

Kirsten’s groundbreaking work includes two significant patents that have the potential to revolutionize cancer treatment. The first patent, titled "Tumor antigens for determining cancer therapy," specifically addresses the treatment of breast cancer, focusing on triple-negative breast cancer. This invention highlights methods and means for cancer treatment utilizing a defined set of tumor antigens.

Her second notable patent, "Individualized vaccines for cancer," offers a patient-specific approach for tumor treatment. This invention emphasizes targeting individual expression patterns of tumor antigens and somatic mutations unique to a patient’s cancer cells. The method recommends inducing a first immune response against specific tumor antigens, followed by a second immune response that targets cancer-specific genetic mutations.

Career Highlights

Kirsten Vormbrock has worked at prominent companies such as BioNTech RNA Pharmaceuticals GmbH and BioNTech SE, further enhancing her expertise and network within the biotechnology sector. Her endeavors in these organizations have played a critical role in advancing cancer therapies and vaccine development.

Collaborations

Throughout her career, Kirsten has collaborated with esteemed colleagues, including Ugur Sahin and Claudia Paret. These partnerships have facilitated the exchange of ideas and propelled innovative approaches to cancer treatment, fostering a collaborative environment that prioritizes patient-focused solutions.

Conclusion

Kirsten Vormbrock’s contributions to the field of cancer research are noteworthy, exemplifying the impact of innovation in medicine. Her patents not only demonstrate her commitment to combating cancer but also signify a leap forward in personalized medicine, offering hope for improved treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…